Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 34Head and Neck Neoplasms 13Squamous Cell Carcinoma of Head and Neck 12Rectal Neoplasms 12Melanoma 12Colorectal Neoplasms 12Carcinoma, Non-Small-Cell Lung 12Lung Neoplasms 11Colonic Neoplasms 10Pancreatic Neoplasms 8Carcinoma, Renal Cell 8Prostatic Neoplasms 7Lymphoma, Follicular 7Breast Neoplasms, Male 7Unspecified Adult Solid Tumor, Protocol Specific 6Lymphoma, Large B-Cell, Diffuse 6Lymphoma, B-Cell, Marginal Zone 6Carcinoma, Ovarian Epithelial 6Ovarian Neoplasms 5Lymphoma, Mantle-Cell 5Lymphoma, Large-Cell, Anaplastic 5Gliosarcoma 5Glioblastoma 5Urinary Bladder Neoplasms 4Stomach Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Oligodendroglioma 4Liver Neoplasms 4Leukemia, Lymphocytic, Chronic, B-Cell 4Kidney Neoplasms 4

Interventions

Gemcitabine 60Cisplatin 38Oxaliplatin 30Capecitabine 28Fluorouracil 21Leucovorin 19pembrolizumab 11Irinotecan 11durvalumab 9130-nm albumin-bound paclitaxel 9Erlotinib Hydrochloride 8Trastuzumab 7Bevacizumab 7Platinum 6Magnetic Resonance Spectroscopy 6Albumin-Bound Paclitaxel 61,2-diaminocyclohexaneplatinum II citrate 6Taxes 5Specimen Handling 5Sorafenib 5Radiotherapy 5Carboplatin 5Docetaxel 4Biopsy 4trifluridine tipiracil drug combination 3dehydroftorafur 3atezolizumab 3Paclitaxel 3Lapatinib 3Interleukin-12 Subunit p35 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Gallbladder Neoplasms × Immunohistochemistry × Clear all
NCT00544193 2015-06-08

Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer

City of Hope Medical Center

Phase 1 Completed
16 enrolled
Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡